What is NDC 10956-703?

10956-703 is the product NDC for Vexia Maximum Strength Urinary Pain Relief, Phenazopyridine hydrochloride 99.5 mg/1 tablet, listed with the FDA by Reese Pharmaceutical Co. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Vexia Maximum Strength Urinary Pain Relief (Phenazopyridine hydrochloride).

Reese Pharmaceutical Co, NDC labeler code 10956. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Vexia Maximum Strength Urinary Pain Relief?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

NDC 10956-703

NDC codes

FDA NDC Directory

Product NDC (as listed)10956-703Labeler and product segments. Claims need a package NDC.

Product NDC at billing width10956-0703Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
10956-703-24	1095607032410956070324	1 BLISTER PACK in 1 CARTON (10956-703-24) / 24 TABLET in 1 BLISTER PACKMarketed from May 24, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Vexia Maximum Strength Urinary Pain Relief
Generic name (nonproprietary): phenazopyridine hydrochloride
Active ingredients: Phenazopyridine hydrochloride — 99.5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Reese Pharmaceutical CoNDC labeler code 10956
Product type: Over-the-counter drug
Marketing category: Unapproved drug (other)
Marketing start: May 24, 2023
Listing expires: Dec 31, 2026
Identifiers: Product ID 10956-703_117fb757-2c46-4923-855d-4438e1976e49SPL ID 117fb757-2c46-4923-855d-4438e1976e49SPL set ID 5fbc47d2-cecd-4187-9bcc-51b1d0b7695dRxCUI 1094147UNII 0EWG668W17

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N410956070324 followed by a unit qualifier and the quantity

Package 10956-0703-24. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 29, 2025.

Indications (excerpt from the label)

Use Fast relief from urinary pain, burning, urgency and frequency associated with urinary tract infections.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 10956-703

What is NDC 10956-703?: 10956-703 is the product NDC for Vexia Maximum Strength Urinary Pain Relief, Phenazopyridine hydrochloride 99.5 mg/1 tablet, listed with the FDA by Reese Pharmaceutical Co. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Vexia Maximum Strength Urinary Pain Relief (Phenazopyridine hydrochloride).
What is the active ingredient?: Phenazopyridine hydrochloride.
Who is the labeler?: Reese Pharmaceutical Co, NDC labeler code 10956. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Vexia Maximum Strength Urinary Pain Relief?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Vexia Maximum Strength Urinary Pain Relief (Phenazopyridine hydrochloride) NDC 10956-703